Alzheimer's disease

The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease
Yahoo/Benzinga
Fri, 02/9/18 - 12:00 am
Alzheimer's disease
R&D
Namzaric-maker Allergan aims hopeful Alzheimer’s message at caregivers
Fierce Pharma
Wed, 01/31/18 - 10:58 am
Namzaric
Allergan
Alzheimer's disease
drug ads
Takeda and Zinfandel write off yet another Alzheimer’s PhIII after Actos fails a key interim test
Endpoints
Thu, 01/25/18 - 09:37 am
Takeda
Zinfandel Pharmaceuticals
Actos
Alzheimer's disease
Eli Lilly finally published its disastrous EXPEDITION3 data, a costly lesson in rethinking Alzheimer’s
Endpoints
Thu, 01/25/18 - 09:31 am
Eli Lilly
clinical trials
Alzheimer's disease
solanezumab
A new Alzheimer’s drug, once worth billions, is headed for the trash
Stat
Mon, 01/8/18 - 11:45 am
Alzheimer's disease
Axovant Sciences
intepirdine
dementia with Lewy bodies
J&J does Alzheimer’s gene therapy deal, along with 14 other new collaborations
Endpoints
Fri, 01/5/18 - 10:31 am
JNJ
Alzheimer's disease
gene therapy
innovation
R&D
Dermala
Holobiome Corporation
Beacon Discovery
Looking for an early success in PhII Alzheimer’s study, Biogen and Eisai just racked up the latest setback
Endpoints
Thu, 12/21/17 - 10:26 am
Biogen
Eisai
clinical trials
Alzheimer's disease
BAN2401
Denali pulls off 2017’s biggest biotech IPO, pocketing $250M for Parkinson’s, Alzheimer’s trials
Fierce Biotech
Fri, 12/8/17 - 10:50 am
Denali
IPOs
Alzheimer's disease
Parkinson's Disease
Gloomy results from the research for an Alzheimer’s therapy
GoinPharma
Thu, 11/30/17 - 09:54 am
Alzheimer's disease
Merck
Eli Lilly
Lundbeck
Biogen
Denali Therapeutics
Yumanity Therapeutics
drug development
Eisai tracking device keeps tabs on out-and-about dementia patients
Fierce Pharma
Wed, 11/29/17 - 10:04 am
Eisai
dementia
Mamorio
devices
Me-Mamorio
Alzheimer's disease
In the search for Alzheimer’s drugs, researchers must look beyond beta amyloid
Stat
Sun, 11/19/17 - 09:49 am
R&D
drug development
Alzheimer's disease
beta amyloid
Bill Gates
If An Alzheimer's Drug Succeeds Could Our Health System Handle it?
Forbes
Wed, 11/15/17 - 08:32 am
Alzheimer's disease
Bill Gates
IPO to Fuel Denali’s Drugs for Alzheimer’s, Other Brain Diseases
Xconomy
Tue, 11/14/17 - 07:55 am
Denali Therapeutics
IPOs
Alzheimer's disease
Roivant CEO: Yes, we failed in Alzheimer’s, but we’re not giving up
Fierce Biotech
Sat, 11/11/17 - 11:04 am
Roivant
Alzheimer's disease
Vivek Ramaswamy
Novartis and Amgen launch new Alzheimer’s study
Endpoints
Thu, 11/2/17 - 10:12 pm
Novartis
Amgen
Alzheimer's disease
CNP520
clinical trials
Why Do Alzheimer’s Drugs Fail? Japanese Researchers May Have Found an Answer
Xtalks
Thu, 10/26/17 - 09:35 pm
Alzheimer's disease
Japan
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
Endpoints
Tue, 10/24/17 - 09:10 am
AbbVie
Alzheimer's disease
Alector
R&D
Eisai shows confidence in Biogen's Alzheimer's drug
Biopharma Dive
Mon, 10/23/17 - 09:49 pm
Eisai
Biogen
Alzheimer's disease
aducanumab
Alzheimer’s: Ionis Initiates phase I/II trial for antisense drug
GoinPharma
Mon, 10/16/17 - 09:37 pm
Alzheimer's disease
Ionis Pharmaceuticals
IONIS-MAPTRx
antisense
CNN investigation exposes inappropriate use of drug in nursing homes
CNN
Thu, 10/12/17 - 10:14 pm
Nuedexta
Avanir Pharmaceuticals
pseudobulbar affect
Alzheimer's disease
off-label

Pages